Bildnachweis: Pexels, VC Magazin, Pixabay. The biotech sector is powering a strong first half year for the Swiss venture ...

Bildnachweis: Insempra, Forbion. Biotechnology is one of the most promising key industries – with the potential to achieve ...

Bildnachweis: Tubulis. Tubulis wants to improve the efficacy of cancer therapies by using antibody drug conjugates (ADCs).

Bildnachweis: ITM. The radiopharmaceutical industry is entering a new era. Driven by clinical breakthroughs, regulatory ...

Bildnachweis: MIG Capital, VC Magazin, Pixabay. The animal health market is booming – and it’s quickly emerging as an ...

Bildnachweis: mbiomics, MIG Capital. mbiomics, based in Neuried near Munich, is pursuing an innovative ‘microbiome ...

Bildnachweis: CanChip, Steven Ritzer Photography, Startup Verband. Ghazaleh Madani, CEO of the biotech start-up CanChip, ...

Bildnachweis: Trophic Communications, VC Magazin, Pixabay. With over three decades in strategic communications and a track record with leaders like BioNTech and Tubulis, Gretchen Schweitzer brings ...

There are many uncertainties in the world, but this much is certain: the demand for innovative life sciences solutions will continue to grow, from research to therapy development. Despite regulatory ...

Bildnachweis: Taylor Wessing, VentureCapital Magazin. When using AI in clinical trials, stakeholders point to the challenges associated with the use of AI in clinical trials, amongst others the need ...

Bildnachweis: plancraft, VentureCapital Magazin. Plancraft digitalisiert Verwaltungsprozesse für Handwerksbetriebe – von der ...

Bildnachweis: Patrycia Lukas. Zum 13. Oktober 2025 wird Sebastian Borek neuer Geschäftsführer des High-Tech Gründerfonds ...